To the Editor:Bronchiectasis is a chronic respiratory disorder characterized by recurrent cough,sputum production,and respiratory infections.Management of bronchiectasis has got an increased emphasis in recent years.[...To the Editor:Bronchiectasis is a chronic respiratory disorder characterized by recurrent cough,sputum production,and respiratory infections.Management of bronchiectasis has got an increased emphasis in recent years.[1]Patients with bronchiectasis should undergo routine monitoring in order to identify disease progression and modify treatment when necessary.In recent years,three composite disease-specific systems have been developed,which are verified for evaluating bronchiectasis severity and predicting prognosis:bronchiectasis severity index(BSI),FACED(F:forced expiratory volume in 1 s%predicted[FEV1%pred],A:age,C:presence of chronic colonisation by Pseudomonas aeruginosa,E:radiological extension[number of pulmonary lobes affected],D:dyspnoea)and FACED plus exacerbations in the previous year(E-FACED).[2,3,4]All three scoring systems classify patients into low,moderate,and high risk groups by different thresholds,respectively.展开更多
基金This work was supported by a grant from the Beijing Municipal Administration of High Level Health Technical Personnel Ttraining Plan,China(No.2015-3-027)。
文摘To the Editor:Bronchiectasis is a chronic respiratory disorder characterized by recurrent cough,sputum production,and respiratory infections.Management of bronchiectasis has got an increased emphasis in recent years.[1]Patients with bronchiectasis should undergo routine monitoring in order to identify disease progression and modify treatment when necessary.In recent years,three composite disease-specific systems have been developed,which are verified for evaluating bronchiectasis severity and predicting prognosis:bronchiectasis severity index(BSI),FACED(F:forced expiratory volume in 1 s%predicted[FEV1%pred],A:age,C:presence of chronic colonisation by Pseudomonas aeruginosa,E:radiological extension[number of pulmonary lobes affected],D:dyspnoea)and FACED plus exacerbations in the previous year(E-FACED).[2,3,4]All three scoring systems classify patients into low,moderate,and high risk groups by different thresholds,respectively.
